Close Menu

NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market on Thursday that its first quarter revenues grew 19 percent year over year on strong demand for the company's Helios and Hyperion imaging mass cytometry systems.

For the three months ended March 31, 2019, Fluidigm tallied $30.1 million in revenues, up from $25.3 million a year ago and besting analysts' consensus estimate of $29.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.